Dulaglutide for Weight Reduction in Diabetic Patients: Efficacy and Safety Analysis
Analysis of dulaglutide efficacy and safety for weight reduction in diabetic patients confirms meaningful weight loss with acceptable tolerability profile.
Quick Facts
What This Study Found
Analysis of dulaglutide efficacy and safety for weight reduction in diabetic patients confirms meaningful weight loss with acceptable tolerability profile.
Key Numbers
Retrospective study from Saudi Arabia measuring weight loss and glycemic control outcomes with dulaglutide in T2D patients.
How They Did This
Methodology in publication.
Why This Research Matters
Relevant to peptide-based therapeutic applications.
The Bigger Picture
Contributes to peptide therapeutic evidence.
What This Study Doesn't Tell Us
Limitations in publication.
Questions This Raises
- ?Long-term implications?
- ?Comparison to evidence?
- ?Next research?
Trust & Context
- Key Stat:
- Key finding Analysis of dulaglutide efficacy and safety for weight reduction in diabetic patients confirms meani
- Evidence Grade:
- Based on study design.
- Study Age:
- Published in 2025.
- Original Title:
- Efficacy and Safety of Dulaglutide for Weight Reduction Among Diabetic Patients in Saudi Arabia: A Retrospective Cohort Study.
- Published In:
- Cureus, 17(7), e88424 (2025)
- Authors:
- Alonazi, Gadah K, Alawuad, Lamia A
- Database ID:
- RPEP-09893
Evidence Hierarchy
Frequently Asked Questions
What does this mean?
Analysis of dulaglutide efficacy and safety for weight reduction in diabetic patients confirms meaningful weight loss with acceptable tolerability profile.
How reliable?
Consult publication and provider.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09893APA
Alonazi, Gadah K; Alawuad, Lamia A. (2025). Efficacy and Safety of Dulaglutide for Weight Reduction Among Diabetic Patients in Saudi Arabia: A Retrospective Cohort Study.. Cureus, 17(7), e88424. https://doi.org/10.7759/cureus.88424
MLA
Alonazi, Gadah K, et al. "Efficacy and Safety of Dulaglutide for Weight Reduction Among Diabetic Patients in Saudi Arabia: A Retrospective Cohort Study.." Cureus, 2025. https://doi.org/10.7759/cureus.88424
RethinkPeptides
RethinkPeptides Research Database. "Efficacy and Safety of Dulaglutide for Weight Reduction Amon..." RPEP-09893. Retrieved from https://rethinkpeptides.com/research/alonazi-2025-efficacy-and-safety-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.